Sign inJoin waitlistJoin the waitlist

MA

Michael Alpert

Physician · Melrose-Wakefield Hospital

Credentials: · · ·

History

Melrose-Wakefield Hospital
2022–Present

Psychiatry
Cambridge Health Alliance
2014–2017
Yale Univ Sch of Med
2010–2014

Research

Immune-correlates analysis of an HIV-1 vaccine efficacy trial
New England Journal of Medicine · 2012 · 1,590 citations
Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination
Science Translational Medicine · 2014 · 409 citations
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family
Journal of Virology · 2012 · 330 citations

Barton Haynes
4 papers
JK
Jerome Kim
4 papers
NM
Nelson Michael
4 papers
CP
Casey Paleos
2 papers
Frederick Altice
2 papers
Juliana McElrath
2 papers
KO
Kelley O'Donnell
2 papers
MR
Merlin Robb
2 papers
MM
Michael Mithoefer
2 papers
RR
Rajeev Raghavan
2 papers
AY
Albert Yeung
1 paper
Ann Chahroudi
1 paper · 1 as a fellow

Grants

Process Development for Manufacturing eCD4-Ig
National Institute of Allergy and Infectious Diseases · R44
Contact PI · $1.3M · Emmune, Inc
2023–2028
An AAV-Mediated Functional Cure and Its Impact on the Reservoir
National Institute of Allergy and Infectious Diseases · U19
Project lead · $2.3M · Boston Children's Hospital
2020–2027
Non-Viral Gene Therapy to Treat and Prevent Atherosclerosis
National Heart, Lung, and Blood Institute · R44
Contact PI · $299.7K · Emmune, Inc
2026–2027
PK, Tolerability, and Toxicology Studies for eCD4-Ig as a Long-Acting Recombinant Protein Therapeutic
National Institute of Allergy and Infectious Diseases · R44
Contact PI · $299.4K · Emmune, Inc
2026–2027